This company recently went public with an IPO on Friday, June 6th 2025. They issued 7,900,000 shares at $19.00 per share. We will continue to update data for OMDA as it becomes available. Omada Health (OMDA) Competitors $15.16 -0.58 (-3.68%) As of 06/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock OMDA vs. ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, NTRA, and FMSShould you be buying Omada Health stock or one of its competitors? The main competitors of Omada Health include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), and Fresenius Medical Care (FMS). These companies are all part of the "healthcare" industry. Omada Health vs. Its Competitors Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Fresenius Medical Care Omada Health (NASDAQ:OMDA) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, community ranking, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations. Which has higher earnings and valuation, OMDA or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmada HealthN/AN/AN/AN/AN/AAclarion$54.60KN/AN/AN/AN/A Does the media prefer OMDA or ACONW? In the previous week, Omada Health had 3 more articles in the media than Aclarion. MarketBeat recorded 3 mentions for Omada Health and 0 mentions for Aclarion. Aclarion's average media sentiment score of 0.00 beat Omada Health's score of -0.33 indicating that Aclarion is being referred to more favorably in the news media. Company Overall Sentiment Omada Health Neutral Aclarion Neutral Does the MarketBeat Community prefer OMDA or ACONW? Omada Health and Aclarion both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformOmada HealthOutperform VotesNo VotesUnderperform Votes1100.00% AclarionN/AN/A Is OMDA or ACONW more profitable? Company Net Margins Return on Equity Return on Assets Omada HealthN/A N/A N/A Aclarion N/A N/A N/A SummaryAclarion beats Omada Health on 2 of the 3 factors compared between the two stocks. Get Omada Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OMDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMDA vs. The Competition Export to ExcelMetricOmada HealthMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$440.33M$7.31B$5.32B$8.56BDividend YieldN/A2.82%5.32%4.20%P/E RatioN/A26.2225.9419.01Price / SalesN/A28.40422.95156.36Price / CashN/A17.2835.6355.74Price / BookN/A6.357.845.05Net IncomeN/A$230.16M$3.15B$249.31M7 Day PerformanceN/A-3.41%-2.64%-1.81%1 Month PerformanceN/A6.05%4.38%2.30%1 Year PerformanceN/A27.84%36.12%15.18% Omada Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMDAOmada HealthN/A$15.16-3.7%N/AN/A$440.33MN/A0.00849News CoverageAnalyst UpgradeACONWAclarionN/A$0.04-0.3%N/A-23.8%$0.00$54.60K0.007Positive NewsAONCAmerican Oncology NetworkN/A$11.57+5.2%N/A+1,015.8%$0.00$1.34B0.001,520Gap UpDHACWDigital Health AcquisitionN/A$0.04-23.7%N/AN/A$0.00N/A0.00N/AGap DownLFMDPLifeMDN/A$24.63+3.3%N/A+5.3%$0.00$234.01M0.00230Short Interest ↓OTRKPOntrakN/A$0.22-4.0%N/A-32.9%$0.00$10.84M0.00250Gap DownPIIIWP3 Health PartnersN/A$0.01-1.1%N/A-86.3%$0.00$1.49B0.00500TALKWTalkspaceN/A$0.08+1.3%N/A-42.2%$0.00$194.36M0.00500Gap DownTOIIWOncology InstituteN/A$0.06-15.0%N/A+188.3%$0.00$403.15M0.00660NTRANatera1.7782 of 5 stars$165.63+0.2%$184.63+11.5%+51.7%$22.69B$1.83B-94.413,020Positive NewsFMSFresenius Medical Care3.1266 of 5 stars$28.83+0.8%$27.80-3.6%+35.4%$16.92B$19.49B23.83123,200News CoveragePositive NewsShort Interest ↓ Related Companies and Tools Related Companies Aclarion Competitors American Oncology Network Competitors Digital Health Acquisition Competitors LifeMD Competitors Ontrak Competitors P3 Health Partners Competitors Talkspace Competitors Oncology Institute Competitors Natera Competitors Fresenius Medical Care Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OMDA) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhat 99% of investors are missing about Chinese AIChinese AI chatbot DeepSeek's release put the spotlight on AI and turned the tech world on its head. But 99...Weiss Ratings | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omada Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omada Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OMDA Stock Free OMDA Stock Alerts